ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,770.20
      0.55%
      US Tech 100
      19,636.04
      0.55%
      Dow Jones
      42,801.72
      0.52%
      Brent Oil
      70.235
      0.00%
      Bitcoin
      86,086.18
      -0.08%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Sutro Biopharma Inc (STRO) Quote

      Sutro Biopharma Inc

      Sutro Biopharma Inc (STRO)

      NASDAQ
      1.50
      0.03
      (2.04%)
      Closed March 08 4:00PM
      Delayed by 15 minutes
      1.50
      -0.005
      (-0.33%)
      After Hours: 6:21PM
      Delayed by 15 minutes

      Professional-Grade Tools, for Individual Investors.

      Premium

      Key stats and details

      Current Price
      1.50
      Bid
      1.44
      Ask
      4.81
      Volume
      783,623
      1.48 Day's Range 1.59
      1.32 52 Week Range 6.13
      Market Cap
      123.688M
      Previous Close
      1.47
      Open
      1.49
      Last Trade
      3
      @
      1.58
      Last Trade Time
      Financial Volume
      $ 1,206,694
      VWAP
      1.5399
      Average Volume (3m)
      973,751
      Shares Outstanding
      82,458,725
      Dividend Yield
      -
      PE Ratio
      -1.16
      Earnings Per Share (EPS)
      -1.3
      Revenue
      153.73M
      Net Profit
      -106.79M

      About Sutro Biopharma Inc

      Sutro Biopharma Inc is clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated ce... Sutro Biopharma Inc is clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. Show more

      Sector
      Biological Pds,ex Diagnstics
      Industry
      Biological Pds,ex Diagnstics
      Website
      www.sutrobio.com
      Headquarters
      South San Francisco, California, USA
      Founded
      -
      Sutro Biopharma Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker STRO. The last closing price for Sutro Biopharma was $1.47. Over the last year, Sutro Biopharma shares have traded in a share price range of $ 1.32 to $ 6.13.

      Sutro Biopharma currently has 82,458,725 shares outstanding. The market capitalization of Sutro Biopharma is $121.21 million. Sutro Biopharma has a price to earnings ratio (PE ratio) of -1.16.

      Ask ADVFN Intelligence (AI)

      STRO Latest News

      More News

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      March 06 2025
      STRO (2.04%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      March 04 2025
      STRO (2.04%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      March 04 2025
      STRO (2.04%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      March 04 2025
      STRO (2.04%)

      Form S-8 - Securities to be offered to employees in employee benefit plans
      Edgar (US Regulatory)
      February 27 2025
      STRO (2.04%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      December 10 2024
      STRO (2.04%)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.05-3.225806451611.551.621.3211917341.44794448CS
      4-0.6-28.57142857142.12.11951.329455791.64533979CS
      12-0.67-30.87557603692.172.231.329737511.84217278CS
      26-2.62-63.59223300974.124.81.328715422.54643219CS
      52-3.13-67.60259179274.636.131.328758893.3357406CS
      156-6.67-81.64014687888.179.751.326872264.41033497CS
      260-7.5-83.3333333333928.31.325572847.80039602CS

      STRO - Frequently Asked Questions (FAQ)

      What is the current Sutro Biopharma share price?
      The current share price of Sutro Biopharma is $ 1.50
      How many Sutro Biopharma shares are in issue?
      Sutro Biopharma has 82,458,725 shares in issue
      What is the market cap of Sutro Biopharma?
      The market capitalisation of Sutro Biopharma is USD 121.21M
      What is the 1 year trading range for Sutro Biopharma share price?
      Sutro Biopharma has traded in the range of $ 1.32 to $ 6.13 during the past year
      What is the PE ratio of Sutro Biopharma?
      The price to earnings ratio of Sutro Biopharma is -1.16
      What is the cash to sales ratio of Sutro Biopharma?
      The cash to sales ratio of Sutro Biopharma is 0.8
      What is the reporting currency for Sutro Biopharma?
      Sutro Biopharma reports financial results in USD
      What is the latest annual turnover for Sutro Biopharma?
      The latest annual turnover of Sutro Biopharma is USD 153.73M
      What is the latest annual profit for Sutro Biopharma?
      The latest annual profit of Sutro Biopharma is USD -106.79M
      What is the registered address of Sutro Biopharma?
      The registered address for Sutro Biopharma is 310 UTAH AVE., SUITE 150, SOUTH SAN FRANCISCO, CALIFORNIA, 94080
      What is the Sutro Biopharma website address?
      The website address for Sutro Biopharma is www.sutrobio.com
      Which industry sector does Sutro Biopharma operate in?
      Sutro Biopharma operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      CAPSCapstone Holding Corp
      $ 3.50
      (1,300.00%)
      		36.33k
      ABLVAble View Global Inc
      $ 1.73
      (137.18%)
      		5.13M
      SUNESUNation Energy Inc
      $ 0.402999
      (127.55%)
      		476.73M
      BTOGBit Origin Ltd
      $ 0.6117
      (118.46%)
      		618.03M
      DWTXDogwood Therapeutics Inc
      $ 6.63
      (49.66%)
      		25.77M
      ALBTAvalon GloboCare Corporation
      $ 6.96
      (-36.15%)
      		577.55k
      SCNXScienture Holdings Inc
      $ 1.55
      (-35.68%)
      		1.59M
      ACXPAcurx Pharmaceuticals Inc
      $ 0.4572
      (-29.88%)
      		1.18M
      RETOReTo Eco Solutions Inc
      $ 5.42
      (-27.73%)
      		108.27k
      OCTOEightco Holdings Inc
      $ 1.08
      (-27.03%)
      		336.99k
      BTOGBit Origin Ltd
      $ 0.6117
      (118.46%)
      		618.03M
      SUNESUNation Energy Inc
      $ 0.402999
      (127.55%)
      		476.73M
      NVDANVIDIA Corporation
      $ 112.69
      (1.92%)
      		333.91M
      ICONIcon Energy Corporation
      $ 0.169898
      (17.17%)
      		140.23M
      TSLLDirexion Daily TSLA Bull 2X Trust ETF
      $ 10.675
      (-0.70%)
      		140.05M

      STRO Discussion

      View Posts
      Invest-in-America Invest-in-America 2 months ago
      STRO: I launched this new iHub board today due to the below-pasted reply I got from GOOGLE's (AI) search routine regarding my following question: "Which (under $5.00) NASDAQ stock is the most likely to SOAR hugely in price on 1-2-25?"

      "According to current market analysis, Sutro Biopharma Inc. (STRO), a clinical-stage biopharmaceutical company currently trading under $5, is considered a potential candidate for a significant price jump due to its promising cancer treatment pipeline, particularly its lead drug candidate "luveltamab tazevibulin" currently in mid-phase trials, which could lead to substantial investor interest if clinical trials prove successful; however, investing in any penny stock carries high risk and should be done with thorough research and consideration of potential downsides."

      /////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////
      And "TipRanks" gives STRO a "Strong Buy" rating, for what that's worth. (But its Float is 76-Million, which ain't small.)
      👍️0

      Your Recent History

      NASDAQ
      STRO
      Sutro Biopharma
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads